| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 05/21/2013 | US8445212 Microfluidic structure for detecting biomolecule and microfluidic device comprising the same |
| 05/21/2013 | US8445211 I-Plastin assay method for the in vitro diagnosis of colorectal cancer |
| 05/21/2013 | US8445210 Microfabricated crossflow devices and methods |
| 05/21/2013 | US8445202 Method of detecting colon cancer marker |
| 05/21/2013 | US8445193 Microwell array chip for detecting antigen-specific lymphocytes, method of detecting and method of manufacturing antigen-specific lymphocytes, and method of cloning antigen-specific lymphocyte antigen receptor genes |
| 05/21/2013 | US8444977 Assay method for Alzheimer's disease |
| 05/21/2013 | US8444957 Methods of screening for neoplastic disease states |
| 05/21/2013 | US8444937 In-situ soil nitrate ion concentration sensor |
| 05/21/2013 | US8444932 D-dimer, troponin, and NT-proBNP for pulmonary embolism |
| 05/21/2013 | US8444921 Molecular separators, concentrators, and detectors preparatory to sensor operation, and methods of minimizing false positives in sensor operations |
| 05/21/2013 | US8444621 Sampler cap |
| 05/21/2013 | US8444314 Dampening apparatus and method for single piston pump used in determining the thermal stability of fluids |
| 05/21/2013 | US8443648 Controlled humidification calibration checking of continuous emissions monitoring system |
| 05/21/2013 | US8443589 Diesel oxidation catalyst efficiency diagnostic method |
| 05/21/2013 | DE202013003150U1 Testkit für die Analyse einer Probe A test kit for the analysis of a sample |
| 05/21/2013 | CA2712798C Methods and apparatus for analysis of downhole compositional gradients and applications thereof |
| 05/21/2013 | CA2673293C Focused beam reflectance measurement to optimize desalter performance and reduce downstream fouling |
| 05/21/2013 | CA2631709C Method for measuring hydrophobic contaminants in paper pulp |
| 05/21/2013 | CA2629647C Platelet aggregation assays |
| 05/21/2013 | CA2569988C Phage microarray profiling of the humoral response to disease |
| 05/21/2013 | CA2566101C Novel soluble cd14 antigen |
| 05/21/2013 | CA2561830C Monoclonal antibodies with specificity for fetal erythroid cells |
| 05/21/2013 | CA2560782C Methods and compositions for the detection of cervical disease |
| 05/21/2013 | CA2558946C Novel method for the preparation of embryoid bodies (ebs) and uses thereof |
| 05/21/2013 | CA2556884C Strip ejection system |
| 05/21/2013 | CA2519285C Papanicolau staining process |
| 05/21/2013 | CA2518541C Gonadal function improving agents |
| 05/21/2013 | CA2502403C System for testing paving materials |
| 05/21/2013 | CA2496321E Biomarkers for diagnosing alzheimer's disease |
| 05/21/2013 | CA2496321C Biomarkers for diagnosing alzheimer's disease |
| 05/21/2013 | CA2478011C Bispecific antibody point mutations for enhancing rate of clearance |
| 05/21/2013 | CA2460092C A method of diagnosis and treatment and agents useful for same |
| 05/21/2013 | CA2436666C Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 05/21/2013 | CA2401638C Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 05/21/2013 | CA2363662C Sequences and methods for detection of hiv-1 |
| 05/21/2013 | CA2305385C Human toll homologues |
| 05/21/2013 | CA2279329C Protein fragment complementation assays to detect biomolecular interactions |
| 05/18/2013 | CA2796520A1 Method for identifying cancer drug candidates in drosophila |
| 05/16/2013 | WO2013071301A1 Paper based diagnostic test |
| 05/16/2013 | WO2013071264A1 Combination of kinase inhibitors and uses thereof |
| 05/16/2013 | WO2013071247A1 Gene expression signatures of neoplasm responsiveness to theraphy |
| 05/16/2013 | WO2013071239A1 Cerebrospinal fluid assay |
| 05/16/2013 | WO2013071231A1 Channelrhodopsins for optical control of cells |
| 05/16/2013 | WO2013071175A1 Devices and methods for detection of panton-valentine leukocidin (pvl) |
| 05/16/2013 | WO2013071127A1 Monoclonal antibodies against serotransferrin antigens, and uses therefor |
| 05/16/2013 | WO2013071084A1 System and method for color preparation and management |
| 05/16/2013 | WO2013071063A1 Brown adipocyte progenitors in human skeletal muscle |
| 05/16/2013 | WO2013071050A1 Brown adipocyte progenitors in human skeletal muscle |
| 05/16/2013 | WO2013070990A1 Co-binder assisted assay methods |
| 05/16/2013 | WO2013070962A1 Methods and uses for metabolic profiling for clostridium difficile infection |
| 05/16/2013 | WO2013070953A1 Lysosomal enzyme assay methods and compositions |
| 05/16/2013 | WO2013070950A1 Identification of a dna methylation marker for blood-based detection of ovarian cancer |
| 05/16/2013 | WO2013070894A1 Method of identifying prebiotics and compositions containing the same |
| 05/16/2013 | WO2013070893A1 Method of making cosmetic compositions containing a prebiotic |
| 05/16/2013 | WO2013070891A1 Method of identifying prebiotics and compositions containing the same |
| 05/16/2013 | WO2013070853A1 Multiple potential based chronoamperometric free chlorine sensors |
| 05/16/2013 | WO2013070849A1 Screening methods for ocular irritation and toxicity |
| 05/16/2013 | WO2013070839A1 Biomarkers for bladder cancer and methods using the same |
| 05/16/2013 | WO2013070807A1 Niche targeting of quiescent cancer stem cells |
| 05/16/2013 | WO2013070741A1 Methods and materials for regulating natriuretic polypeptide function |
| 05/16/2013 | WO2013070653A1 Metallic nanoparticle synthesis with carbohydrate capping agent |
| 05/16/2013 | WO2013070521A1 Method of predicting breast cancer prognosis |
| 05/16/2013 | WO2013070468A1 Glypican-3-specific antibody and uses thereof |
| 05/16/2013 | WO2013070412A1 Method for estimating sediment content of a hydroprocessed hydrocarbon-containing feedstock |
| 05/16/2013 | WO2013070389A1 Method for predicting sediment content of a hydroprocessed hydrocarbon product |
| 05/16/2013 | WO2013070339A1 Systems, devices, and/or methods for solar cells comprising a light amplification element |
| 05/16/2013 | WO2013070338A1 Systems, devices, and/or methods for preparation of graphene and graphene hybrid composite via the pyrolysis of milled solid carbon sources |
| 05/16/2013 | WO2013070172A1 Sensing system for detecting a substance in a dialysate |
| 05/16/2013 | WO2013070167A1 The use of a synthetic dna-antibody complex as external reference for chromatin immunoprecipitation |
| 05/16/2013 | WO2013070089A1 Method and materials for the diagnosis of prostate cancers |
| 05/16/2013 | WO2013070088A1 Methods and materials for determining the efficacy of prostate cancer therapies |
| 05/16/2013 | WO2013070056A1 Production of a low-molecular-weight recombinant metalloproteinaise (50 kda) oftrichomonas vaginalis and identification of the gene that codes for said low-molecular-weight metalloproteinase (50 kda) that is expressed differentially in the presence of zn+2 |
| 05/16/2013 | WO2013070055A1 Production of anti tvmp50r polyclonal antibodies that can be used in the diagnosis of trichomonas vaginalis in men |
| 05/16/2013 | WO2013070033A1 Strip for diagnosing osteoporosis and bone turnover rate |
| 05/16/2013 | WO2013070032A1 System for diagnosing osteoporosis and bone turnover rate and method for same |
| 05/16/2013 | WO2013069895A1 Personal blood glucose meter and abnormal measurement detection method using same |
| 05/16/2013 | WO2013069773A1 Base-supporting labeling method, base sequence information acquisition method, and base-supporting labeled single-stranded nucleic acid |
| 05/16/2013 | WO2013069749A1 Method for measuring physiologically active substance of biological origin |
| 05/16/2013 | WO2013069741A1 Antibody specific to profilaggrin c-terminal domain, and use thereof |
| 05/16/2013 | WO2013069010A1 Methods for individually optimizing a cancer treatment |
| 05/16/2013 | WO2013068758A1 Antibody specific for trans - resveratrol and use thereof |
| 05/16/2013 | WO2013068695A1 Compact device for detecting gases and vapours comprising an integrated test gas charge |
| 05/16/2013 | WO2013068685A1 Method for detecting delta haemolysin of staphylococcus aureus by mass spectrometry directly using a bacterial population |
| 05/16/2013 | WO2013068572A2 Blood sample assay method |
| 05/16/2013 | WO2013068557A1 Virus infectable stem cells |
| 05/16/2013 | WO2013068475A1 Dynamic of sflt-1 or endoglin/plgf ratio as an indicator for imminent preeclampsia and/or hellp syndrome |
| 05/16/2013 | WO2013068432A1 Early diagnostic of neurodegenerative diseases |
| 05/16/2013 | WO2013068431A1 New treatment for neurodegenerative diseases |
| 05/16/2013 | WO2013068374A2 Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment |
| 05/16/2013 | WO2013068373A2 Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment |
| 05/16/2013 | WO2013068372A1 A method for determining the propensity for calcification |
| 05/16/2013 | WO2013068347A1 Prognostic method for checking efficacy of micro rna-122 inhibitors in hcv+ patients |
| 05/16/2013 | WO2013068011A1 New method for evaluation of target in histological sample |
| 05/16/2013 | WO2013067979A1 Method for determination of the concentration of uromodulin in serum and it's use as a serologic marker for the diagnosis of nephropathy |
| 05/16/2013 | WO2013067978A1 A method for anchoring carbon nanoparticles onto surface of a base material and a substrate comprising base material with anchored layer of carbon nanoparticles |
| 05/16/2013 | WO2013067750A1 Polyclonal antibody immunologic mass spectrometry kit of liver cancer marker |
| 05/16/2013 | WO2013067640A1 Evaluation of skin lesions by raman spectroscopy |
| 05/16/2013 | WO2013067639A1 Use of rank/rankl antagonists for treating neuromuscular disorders, genetic myopathies and/or non genetic myopathies and/or for regulating skeletal and cardiac muscle disuse, diseases and aging |
| 05/16/2013 | WO2013044222A3 Systems and methods for providing microfluidic devices |
| 05/16/2013 | WO2013043878A3 Alternative splicing variants of genes associated with prostate cancer risk and survival |